John A. Ward

Array ( [id] => 6099310 [patent_doc_number] => 20020053092 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-05-02 [patent_title] => 'Nucleic acid constructs containing a cyclin A1 promoter, and kit' [patent_app_type] => new [patent_app_number] => 09/918889 [patent_app_country] => US [patent_app_date] => 2001-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23113 [patent_no_of_claims] => 132 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0053/20020053092.pdf [firstpage_image] =>[orig_patent_app_number] => 09918889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6554568 [patent_doc_number] => 20020164333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Bifunctional molecules and vectors complexed therewith for targeted gene delivery' [patent_app_type] => new [patent_app_number] => 09/903327 [patent_app_country] => US [patent_app_date] => 2001-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 28668 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164333.pdf [firstpage_image] =>[orig_patent_app_number] => 09903327 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6433844 [patent_doc_number] => 20020127713 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Specific tolerance in transplantation' [patent_app_type] => new [patent_app_number] => 09/895713 [patent_app_country] => US [patent_app_date] => 2001-06-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 11051 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20020127713.pdf [firstpage_image] =>[orig_patent_app_number] => 09895713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6636637 [patent_doc_number] => 20020086841 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-04 [patent_title] => 'DNA cytokine vaccines and use of same for protective immunity against multiple sclerosis' [patent_app_type] => new [patent_app_number] => 09/887031 [patent_app_country] => US [patent_app_date] => 2001-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 16580 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0086/20020086841.pdf [firstpage_image] =>[orig_patent_app_number] => 09887031 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5040244 [patent_doc_number] => 20070092526 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Polynucleotide vaccine adjuvants and formulations containing cationic surfactants, and methods of use' [patent_app_type] => utility [patent_app_number] => 09/888304 [patent_app_country] => US [patent_app_date] => 2001-06-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 20984 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092526.pdf [firstpage_image] =>[orig_patent_app_number] => 09888304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6787687 [patent_doc_number] => 20030138926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-24 [patent_title] => 'Novel polynucleotides and polypeptides encoded thereby' [patent_app_type] => new [patent_app_number] => 09/882263 [patent_app_country] => US [patent_app_date] => 2001-06-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 41820 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0138/20030138926.pdf [firstpage_image] =>[orig_patent_app_number] => 09882263 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6557990 [patent_doc_number] => 20020194637 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Embryonic or stem-like cell lines produced by cross species nuclear transplantation' [patent_app_type] => new [patent_app_number] => 09/874040 [patent_app_country] => US [patent_app_date] => 2001-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9235 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 97 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20020194637.pdf [firstpage_image] =>[orig_patent_app_number] => 09874040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6046841 [patent_doc_number] => 20020168348 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-14 [patent_title] => 'Allogeneic and and xenogeneic transplantation' [patent_app_type] => new [patent_app_number] => 09/874512 [patent_app_country] => US [patent_app_date] => 2001-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 31165 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0168/20020168348.pdf [firstpage_image] =>[orig_patent_app_number] => 09874512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6535574 [patent_doc_number] => 20020026649 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-02-28 [patent_title] => 'Metastasis models using green fluorescent protein (GFP) as a marker' [patent_app_type] => new [patent_app_number] => 09/870268 [patent_app_country] => US [patent_app_date] => 2001-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7445 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 138 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0026/20020026649.pdf [firstpage_image] =>[orig_patent_app_number] => 09870268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6688330 [patent_doc_number] => 20030032055 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Diagnosis and treatment of medical conditions associated with defective NFkappa B(NF-kappaB) activation' [patent_app_type] => new [patent_app_number] => 09/863049 [patent_app_country] => US [patent_app_date] => 2001-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 28549 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0032/20030032055.pdf [firstpage_image] =>[orig_patent_app_number] => 09863049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1213083 [patent_doc_number] => 06710036 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-03-23 [patent_title] => 'Induction of immune response to antigens expressed by recombinant adeno-associated virus' [patent_app_type] => B2 [patent_app_number] => 09/858728 [patent_app_country] => US [patent_app_date] => 2001-05-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 21792 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/710/06710036.pdf [firstpage_image] =>[orig_patent_app_number] => 09858728 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6843621 [patent_doc_number] => 20030148968 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-07 [patent_title] => 'Techniques and compositions for treating cardiovascular disease by in vivo gene delivery' [patent_app_type] => new [patent_app_number] => 09/847936 [patent_app_country] => US [patent_app_date] => 2001-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 33827 [patent_no_of_claims] => 156 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20030148968.pdf [firstpage_image] =>[orig_patent_app_number] => 09847936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6590085 [patent_doc_number] => 20020041872 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-04-11 [patent_title] => 'Methods of delaying development of CEA-associated tumors using anti-idiotype antibody 3H1' [patent_app_type] => new [patent_app_number] => 09/844736 [patent_app_country] => US [patent_app_date] => 2001-04-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 15188 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20020041872.pdf [firstpage_image] =>[orig_patent_app_number] => 09844736 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6901394 [patent_doc_number] => 20010022977 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-20 [patent_title] => 'Method of inducing resistance to tumor growth' [patent_app_type] => new [patent_app_number] => 09/832382 [patent_app_country] => US [patent_app_date] => 2001-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 10161 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20010022977.pdf [firstpage_image] =>[orig_patent_app_number] => 09832382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6800802 [patent_doc_number] => 20030095966 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-22 [patent_title] => 'Method of blocking tissue destruction by autoreactive T cells' [patent_app_type] => new [patent_app_number] => 09/822851 [patent_app_country] => US [patent_app_date] => 2001-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7228 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0095/20030095966.pdf [firstpage_image] =>[orig_patent_app_number] => 09822851 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6947761 [patent_doc_number] => 20010021395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-09-13 [patent_title] => 'Method for destroying hyperproliferative cells by combined p53 and taxoid treatment' [patent_app_type] => new [patent_app_number] => 09/816144 [patent_app_country] => US [patent_app_date] => 2001-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7034 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0021/20010021395.pdf [firstpage_image] =>[orig_patent_app_number] => 09816144 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6882667 [patent_doc_number] => 20010049139 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-12-06 [patent_title] => 'Hepatic regeneration from hematopoietic stem cells' [patent_app_type] => new [patent_app_number] => 09/816750 [patent_app_country] => US [patent_app_date] => 2001-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 9992 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20010049139.pdf [firstpage_image] =>[orig_patent_app_number] => 09816750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 644724 [patent_doc_number] => 07118743 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-10-10 [patent_title] => 'Bispecific molecules cross-linking ITIM and ITAM for therapy' [patent_app_type] => utility [patent_app_number] => 09/810883 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6591 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/118/07118743.pdf [firstpage_image] =>[orig_patent_app_number] => 09810883 [rel_patent_id] =>[rel_patent_doc_number] =>)